enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. The Good News, Bad News for Belviq: Bad News First... - AOL

   www.aol.com/2013/11/21/the-good-news-bad-news...

   Arena Pharmaceuticals and its lead product, weight loss drug Belviq, have had a difficult run since Belviq's launch in June. On its recent conference call, Arena's marketing partner Eisai reported ...

3. Lorcaserin - Wikipedia

   en.wikipedia.org/wiki/Lorcaserin

   Lorcaserin, marketed under the brand name Belviq, [4] [5] was a weight-loss drug developed by Arena Pharmaceuticals. It reduces appetite by activating serotonin receptor the 5-HT 2C receptor in the hypothalamus , a region of the brain which is known to control appetite. [ 6 ]

4. New Obesity Drug Hits the Market - AOL

   www.aol.com/2013/06/07/new-obesity-drug-hits-the...

   After a long wait, patients now have a choice between two new obesity drugs. They couldn't be more different. Arena Pharmaceuticals' Belviq, the newest offering, looks relatively safe. The top ...

5. The Good News, Bad News for Belviq: ...Now the Good News - AOL

   www.aol.com/news/2013-11-26-the-good-news-bad...

   For premium support please call: 800-290-4726 more ways to reach us

6. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   Lorcaserin (Belviq) was FDA approved for weight loss but was withdrawn from the market because a safety clinical trial shows an increased occurrence of cancer. [ 11 ] Cannabinoid receptor antagonists were developed to treat obesity because researchers noticed that cannabinoid agonists (such as THC , the main pharmacologically active component ...

7. New Obesity Drug Hits the Market - AOL

   www.aol.com/news/2013-06-07-new-obesity-drug...

   For premium support please call: 800-290-4726 more ways to reach us